Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
AFT Pharmaceuticals Limited (ASX: AFP) - Share Price and Research
Current share price for AFP : $2.830 0.12 (4.43%)
AFT Pharmaceuticals Limited (AFP), an ASX-listed company, is a multinational pharmaceutical business with a range of products, both developed itself and in-licensed from third parties. AFT's products cover all major pharmaceutical distribution channels: over the counter, prescription and hospital. Its featured brand includes- Crystaderm, coco-scalp and maxigesic.
AFP General Information +
| ASX Code | AFP |
| Website | http://www.aftpharm.com |
| Industry/Sector | Pharmaceuticals |
| Market Cap ($M) | 296 |
| AFP Share Price | $2.830 |
| Day High | $2.830 |
| Day Low | $2.830 |
| Last Close | $2.710 |
| AFP Share Price Movement | $0.12 ( 4.43% ) |
Prices as at 16:35, 19 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
AFP Related Research
AFT Pharmaceuticals Limited (AFP) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 0.69¢ | 0% | 16 Jun 2023 | 4 Jul 2023 | $2.830 | $2.850 | 0.25% |
See all dividends from AFT Pharmaceuticals Limited (AFP) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
AFT Pharmaceuticals Limited (AFP) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| AFT makes further progress in international markets | 4 Mar 2024 7:32AM | $3.100 | $2.830 | $2.850 | fallen by 8.71% |
| AFT updates operating profit guidance to $23m to $25m | 16 Feb 2024 7:33AM | $3.510 | $2.830 | $2.850 | fallen by 19.37% |
| Maxigesic IV launched in the United States | 6 Feb 2024 8:11AM | $3.440 | $2.830 | $2.850 | fallen by 17.73% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from AFT Pharmaceuticals Limited (AFP) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
AFP Financial Summary
| Year to Mar | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025F | C2 | $17.00 | 17.40% | 16.00 | 1.70 | 0.60% | 0.0% |
| 2024F | C2 | $14.50 | 52.00% | 18.80 | 1.50 | 0.50% | 0.0% |
| 2023A | $9.97 | $9.50 | -46.00% | 34.50 | 1.00 | 0.30% | 0.0% |
AFP Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 F | 2025 F | 2023 A | 2024 F | 2025 F | 2023 A | 2024 F | 2025 F | ||
| AFT Pharmaceuticals (AFP) | $284M | -0.4603 | 0.5195 | 0.1744 | 28.4963 | 18.7543 | 15.9694 | 0.35% | 0.54% | 0.63% |
| Mayne Pharma Group (MYX) | $567M | 0.9287 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Neuren Pharmaceuticals (NEU) | $2,491M | 799.6667 | -0.5504 | 0.6667 | 16.2448 | 36.1296 | 21.6778 | 0.00% | 0.00% | 0.00% |
AFP Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.65 | 18.80 | 4.14 | 0.56 |
| Market | 0.53 | 15.30 | 1.11 | 1.01 |
| Sector | 1.26 | 21.30 | 1.92 | 0.98 |
AFP Directors
| Name | Position | Start Date |
|---|---|---|
| Ms Marree Atkinson | Chief of Staff, Managing Director | 4 Sep 2012 |
| Mr Hartley Atkinson | Founder, Chief Executive Officer, Executive Director | 4 Sep 1997 |
| Mr David Mark Flacks | Non-Executive Chairman, Non-Executive Director | 22 Jun 2015 |
| Mr Andrew Michael Lane | Non-Executive Director | 28 Sep 2023 |
| Dr John Douglas Wilson | Non-Executive Director | 4 Sep 2012 |
| Ms Anita Baldauf | Non-Executive Director | 4 Nov 2020 |
| Dr Ted Witek | Non-Executive Director | 1 Jan 2021 |
AFT Pharmaceuticals Limited (AFP) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 7 Aug 2020 | ATKINSON, Hartley | Issued | Indirect Shares | 137,826 | $2.740 | $377,643.240 |
| 2 Jul 2020 | FLACKS, David | Buy | Indirect Shares | 13,333 | $3.750 | $49,998.750 |
| 2 Jul 2020 | LAMB, Jon | Buy | Indirect Shares | 13,333 | $3.750 | $49,998.750 |
See all changes in directors' interest & trades for AFT Pharmaceuticals Limited (AFP) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
AFP Management
| Name | Position |
|---|---|
| Malcolm Tubby | Chief Financial Officer,Company Secretary |
AFP Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in AFT Pharmaceuticals Limited (AFP). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 722,899,435 (69.51%) | Hartley Campbell Atkinson |
AFP Calendar of Events
| Date | Event |
|---|---|
| 21 November 2024 | Report (Interim) |
| 20 May 2024 | Report (Annual) |
| 20 May 2024 | Report (Prelim) |
FAQs about AFT Pharmaceuticals Limited (AFP)
What is the current share price of AFT Pharmaceuticals Limited (AFP)?
AFT Pharmaceuticals Limited's (AFP) current share price is $2.83. This constitutes a price movement of 0.70% when compared to the share price 7 days ago and is -23.31% below AFP's 12-month high of $3.69 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for AFT Pharmaceuticals Limited (AFP)?
Relative to the previous close share price of $2.71, AFT Pharmaceuticals Limited's (AFP) current share price of $2.83 constitutes a movement of $0.12 or 4.43%. AFT Pharmaceuticals Limited's (AFP) share price movement is -0.70% when compared to 7 days ago and is -23.31% below AFP's 52-week high of $3.69.
What is the 52-week high share price for AFT Pharmaceuticals Limited (AFP)?
AFT Pharmaceuticals Limited's (AFP) 52-week high is $3.69 which was reached on 24 May 2023. Relative to this, AFP's current share price of $2.83 constitutes a -$0.86 or -23.31% drop since that high of $3.69 per AFP share.
What is the 52-week low share price for AFT Pharmaceuticals Limited (AFP)?
AFT Pharmaceuticals Limited's (AFP) 52-week low is $2.50 which was reached on 25 Mar 2024. Relative to this, AFP's current share price of $2.83 constitutes a $0.33 or 13.20% gain since that low of $2.50 per AFP share.
What is the daily average trading volume for AFT Pharmaceuticals Limited (AFP)?
Over the last 12 months, AFT Pharmaceuticals Limited (AFP) has a daily average trading volume of 537 AFP shares per day.
What is the dividend yield for AFT Pharmaceuticals Limited (AFP)?
AFT Pharmaceuticals Limited (AFP) has a current dividend yield of n/a this year. Last year's dividend yield was 0.30%. The dividend yield for AFP is a ratio that tells you the percentage of AFT Pharmaceuticals Limited's (AFP) share price that it pays out in dividends each year.
What was AFT Pharmaceuticals Limited (AFP) last dividend payment?
AFT Pharmaceuticals Limited (AFP) last dividend payment was $0.01 per share and was paid on 4 Jul 2023. This last AFP dividend included 0% franking.
What is the franking level for AFT Pharmaceuticals Limited (AFP)?
AFT Pharmaceuticals Limited (AFP) has a franking level of 0%. Franking represents the tax AFT Pharmaceuticals Limited (AFP) has already paid on any profit it distributes to shareholders as a dividend.
When does AFT Pharmaceuticals Limited (AFP) release its next Annual Report?
AFT Pharmaceuticals Limited (AFP) will release its next Annual Report on 20 May 2024. AFT Pharmaceuticals Limited's (AFP) last annual report was released on 22 May 2023. Click here to view AFT Pharmaceuticals Limited's (AFP) last annual report.
In which sector is AFT Pharmaceuticals Limited (AFP) classified?
AFT Pharmaceuticals Limited (AFP) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Cochlear Limited (COH), and Fisher & Paykel Healthcare Corporation Limited (FPH).
What is the price-to-earnings (P/E) ratio for AFT Pharmaceuticals Limited (AFP)?
The price-to-earnings (P/E) ratio for AFT Pharmaceuticals Limited (AFP) is 18.8. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of AFT Pharmaceuticals Limited's (AFP) share price to its earnings per AFP share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
